title: Clinical outcomes following hospital-wide implementation of prolonged-infusion cefepime and ceftazidime.
authors.affiliation: Pacific University, School of Pharmacy, 222 SE 8th Avenue Suite 451, Hillsboro, OR 97123, USA. Electronic address: Brigg.turner@pacificu.edu.
authors.forename: R Brigg
authors.initials: RB
authors.lastname: Turner
authors.affiliation: West Virginia University, School of Pharmacy, 5706 Medical Center Drive, P.O. Box 9500, Morgantown, WV 26506, USA.
authors.forename: Douglas
authors.initials: D
authors.lastname: Slain
authors.affiliation: West Virginia University Healthcare, 1 Medical Center Drive, P.O. Box 8045, Morgantown, WV 26506, USA.
authors.forename: Karen
authors.initials: K
authors.lastname: Petros
authors.affiliation: West Virginia University Healthcare, 1 Medical Center Drive, P.O. Box 8045, Morgantown, WV 26506, USA.
authors.forename: Lisa A
authors.initials: LA
authors.lastname: Keller
authors.affiliation: West Virginia University, School of Medicine, 1 Medical Center Drive, P.O. Box 9100, Morgantown, WV 26506, USA.
authors.forename: Arif R
authors.initials: AR
authors.lastname: Sarwari
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D000077723:Cefepime; D002442:Ceftazidime / Q000008:administration & dosage*; D002511:Cephalosporins / Q000008:administration & dosage*; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy*; D006761:Hospitals; D006801:Humans; D007262:Infusions, Intravenous / Q000379:methods; D012189:Retrospective Studies; D016019:Survival Analysis; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D000077723:Cefepime; D002442:Ceftazidime